Determination of Vaginal Colonization and the Effect of an Oral Probiotic (PROSALVAG)
NCT ID: NCT05176535
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2021-10-11
2024-05-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaginal Detection of Orally Delivered Probiotic Strains in Healthy Women
NCT07246161
Interventional Study to Evaluate the Effect of the Oral Administration of L.Plantarum on Vaginal Microbiota
NCT04461782
The Impact of Probiotics on Well-being in Women
NCT06507111
Evaluation of the Consumption of a Probiotic on the Load of S. Agalactiae.
NCT04165551
Behavior of Various Galenic Forms of a Probiotic in the Digestive Tract.
NCT03143400
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FertyBiotic Balance
Participants received FertyBiotic Balance one capsule a day
FertyBiotic Balance
Lactobacillus rhamnosus BPL 205, Lactobacillus plantarum BPL207 and Lactobacillus crispatus BPL209
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FertyBiotic Balance
Lactobacillus rhamnosus BPL 205, Lactobacillus plantarum BPL207 and Lactobacillus crispatus BPL209
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Vaginal pH \> 4,5 and low Lactobacillus count or Nugent score of 4-6
* With interest in getting pregnant and ideally in IVF waiting list
* History of recurrent genitourinary infections
Exclusion Criteria
* Current intake of food supplements or probiotics
* Current intake of contraceptives
* Use of oral or vaginal probiotics in the last 6 months
* Hypersensitivity to any of the components of the studied product
* Current vaginal infection
* Pregnant women
* Breastfeeding
* Use of intrauterine device
* Use of spermicide
* Use of cervical caps as hormonal therapy
35 Years
43 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fertypharm
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HM Fertility Centter Vallés
Alcalá de Henares, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-FBB-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.